Company / Current Assets per Share
Catalyst Pharmaceuticals Partners, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.30
FY2025
5-year range
$2.04 / $7.30
FY2021-FY2025
Trend
+41.5%
vs FY2024
Sector context
#96 of 210
Health Care
What the data says
At $7.30, Catalyst Pharmaceuticals Partners, Inc.'s current assets per share ranks #96 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.50 in FY2016 to $7.30 in FY2025.
Based on SEC 10-K filings.
7.30 in FY2025 with a 5-year CAGR of +36.5%.
Improved from $2.05 to $7.30 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +33.8%
- 5-Year CAGR
- +36.5%
- 10-Year CAGR
- -
Sector benchmark
#96 of 210 in Health CareTop 46% of 210This company $7.30 Sector average $170.46
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 41.5% year-over-year.
- Ranks #96 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.30 | +41.5% |
| FY2024 | $5.16 | +152.0% |
| FY2023 | $2.05 | -32.8% |
| FY2022 | $3.05 | +49.4% |
| FY2021 | $2.04 | +32.5% |
| FY2020 | $1.54 | +42.1% |
| FY2019 | $1.08 | +101.4% |
| FY2018 | $0.54 | -47.6% |
| FY2017 | $1.03 | +105.5% |
| FY2016 | $0.50 | -30.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026